Gaining Market Access with New MedTech Innovations: CSSi LifeSciences Partners with Market Strategy Leader, Jaunt

Published April 18, 2024

CSSi LifeSciences Announces Strategic Partnership with Australian States to Facilitate Entry into the US Healthcare Market

Published December 6, 2023

These Four Leading CROs in Maryland are Driving Success in Life Sciences

Published June 8, 2023

Biotoxtech and CSSi LifeSciences Strengthen Business Cooperation for New Drug Development

Published April 19, 2023

SiSaf’s Innovative RNA Therapeutic for Rare Genetic Skeletal Disorders Begins the U.S. Regulatory Process for Orphan Drug Designation

Published October 12, 2022

BioCurity Pharmaceuticals Inc. ('BioCurity' or ‘Company’) Announces Presentation at ACRO Summit 2022 on Sensitizing Head and Neck Cancer to Radiation Using the Company’s Cerium Oxide Nanoparticles | Business Wire

Published March 10, 2021

Tonic Bioventures and CSSi LifeSciences Enter Partnership to Form A New Life Sciences Fund

Published January 6, 2021

Ernesto P. Chanona, Ph.D. Joins CSSi LifeSciences As Director of Business Development

Published January 5, 2021